Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
+$513M |
| 2 |
Medtronic
MDT
|
+$497M |
| 3 |
Apple
AAPL
|
+$432M |
| 4 |
L3Harris
LHX
|
+$340M |
| 5 |
Danaher
DHR
|
+$254M |
Top Sells
| 1 |
Mastercard
MA
|
+$427M |
| 2 |
AbbVie
ABBV
|
+$387M |
| 3 |
LLL
L3 Technologies, Inc.
LLL
|
+$315M |
| 4 |
CoStar Group
CSGP
|
+$270M |
| 5 |
Abbott
ABT
|
+$258M |
Sector Composition
| 1 | Technology | 25.79% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 12.76% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Mondelez International
MDLZ
$80.6B
| $53.9M | 0.03% |
974,029
+435,068
| +81% | +$24.1M |
|
552
Kohl's
KSS
$1.8B
| $53.8M | 0.03% |
1,083,625
-907,069
| -46% | -$45M |
|
553
Yum China
YUMC
$16.2B
| $53.7M | 0.03% |
1,182,771
+99,201
| +9% | +$4.51M |
|
554
Paylocity
PCTY
$9.34B
| $53.7M | 0.03% |
550,712
+98,423
| +22% | +$9.6M |
|
555
J&J Snack Foods
JJSF
$2.08B
| $53.7M | 0.03% |
279,514
+513
| +0.2% | +$98.5K |
|
556
Valvoline
VVV
$5B
| $53.6M | 0.03% |
2,431,082
+261,075
| +12% | +$5.75M |
|
557
Arch Capital
ACGL
$33.8B
| $53.4M | 0.03% |
1,272,813
+144,935
| +13% | +$6.08M |
|
558
Avery Dennison
AVY
$12.8B
| $53.3M | 0.03% |
469,058
+189,361
| +68% | +$21.5M |
|
|
GWPH
559
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $53.3M | 0.03% |
463,016
-548
| -0.1% | -$63K |
|
|
XLRN
560
DELISTED
Acceleron Pharma Inc.
XLRN
| $53.2M | 0.03% |
1,345,405
+35,736
| +3% | +$1.41M |
|
561
IDEX
IEX
$12.1B
| $52.5M | 0.03% |
320,331
+48,378
| +18% | +$7.93M |
|
|
IMMU
562
DELISTED
Immunomedics Inc
IMMU
| $52.3M | 0.03% |
3,944,509
-11,780
| -0.3% | -$156K |
|
|
ABMD
563
DELISTED
Abiomed Inc
ABMD
| $52.2M | 0.03% |
293,591
-263,098
| -47% | -$46.8M |
|
564
Rollins
ROL
$27.3B
| $52.1M | 0.03% |
2,295,840
-723,872
| -24% | -$16.4M |
|
565
Enanta Pharmaceuticals
ENTA
$178M
| $52M | 0.03% |
865,309
-79,478
| -8% | -$4.78M |
|
566
Hancock Whitney
HWC
$5.35B
| $51.9M | 0.03% |
1,356,009
+175,750
| +15% | +$6.73M |
|
567
WSFS Financial
WSFS
$3.15B
| $51.6M | 0.03% |
1,170,575
+337,674
| +41% | +$14.9M |
|
|
DRE
568
DELISTED
Duke Realty Corp.
DRE
| $51.2M | 0.03% |
1,507,849
+373,139
| +33% | +$12.7M |
|
569
Equifax
EFX
$30.3B
| $51.1M | 0.03% |
363,018
+138,017
| +61% | +$19.4M |
|
570
Trex
TREX
$6.43B
| $51M | 0.03% |
1,122,532
+2,220
| +0.2% | +$101K |
|
|
INST
571
DELISTED
Instructure, Inc.
INST
| $51M | 0.03% |
1,316,204
-2,558
| -0.2% | -$99.1K |
|
572
Edison International
EIX
$21.4B
| $50.9M | 0.03% |
674,351
-215,340
| -24% | -$16.2M |
|
573
Omnicell
OMCL
$1.46B
| $50.6M | 0.03% |
700,745
+2,007
| +0.3% | +$145K |
|
574
Willis Towers Watson
WTW
$32.2B
| $50.5M | 0.03% |
261,844
+145,533
| +125% | +$28.1M |
|
|
CARO
575
DELISTED
Carolina Financial Corp.
CARO
| $50.5M | 0.03% |
1,421,258
+90,985
| +7% | +$3.23M |
|